Vladislav Viktorovich Kovalev

Vladislav Viktorovich Kovalev

Auto-generated profile, based on publicly available information

Vladislav Viktorovich Kovalev

Ural State Medical University, Yekaterinburg, Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2020 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
KKKovalev V.V. Kovalev
Kovalev V.V. Kovalev
KKKudryavtseva E.V. Kudryavtseva
Kudryavtseva E.V. Kudryavtseva

17 March 2023 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
DID. K. Islamidi
D. K. Islamidi
NBN. S. Belyh
N. S. Belyh
VKV. V. Kovalev
V. V. Kovalev
NMN. M. Milyaeva
N. M. Milyaeva
Introduction. In the structure of gynecological morbidity intrauterine pathology occupies a leading position because of its high frequency and negative impact on the reproductive health of a woman. Endometrial pathology is numerous and includes endometrial hyperplasia and polyps, endometrial cancer, abnormal uterine bleeding and dysmenorrhea, endometriosis and Asherman's syndrome. Pathological changes of the endometrium in women with reproductive problems, such as infertility, habitual miscarriage, are particularly relevant.The aim of the work is to estimate the contribution of endometrial microbiota in the development of endometrial pathological processes and identify possible pathogens for the development of this process on the basis of scientific literature data.Materials and methods. Data analysis and systematization were performed on the basis of scientific publications in the PubMed, Google scholar, and Scopus databases for the period 2010–2021. For the final scientific review 65 sources were selected.Results and discussion. This article presents findings on the role of the uterine cavity microbiota and its contribution to endometrial pathology such as endometrial polyps and hyperplasia, adenomyosis and uterine bleeding, infertility and intrauterine synechiae. The correction of an altered microbiota opens up new insights into the development of uterine diseases and new therapeutic options.Conclusion. Numerous studies of the uterine cavity microbiota show its undoubted role in the development of uterine cavity pathology. However, the data obtained are quite contradictory. Further study of the uterine microbiota is necessary for a deeper understanding of the pathogenesis of endometrial pathological processes.

5 August 2024 in OBM Genetics
Verified
Journal Article
Open access
PDF file
EKElena V. Kudryavtseva
Elena V. Kudryavtseva
SFSergey N. Fedenev
Sergey N. Fedenev
IKIlya Kanivets
Ilya Kanivets
ATAnastasiya N. Troitskaya
Anastasiya N. Troitskaya
VKVladislav V. Kovalev
Vladislav V. Kovalev
Assisted reproductive technologies (ART), including in vitro fertilization (IVF), are modern medical technologies widely used in developed countries. A frequent complication of pregnancy resulting from ART is miscarriage. The leading cause of miscarriage, both sporadic and recurrent, is chromosomal abnormalities (CA) of the embryo. To compare the frequency and structure of chromosomal abnormalities (CA) of the embryo during miscarriages after IVF and natural conception. Retrospective cohort comparative study. The study, conducted in 2018-2022, included 1,000 products of conception (POCs) samples from patients with miscarriage. The study participants were divided into 2 groups depending on the origin of pregnancy: group 1 – women whose pregnancy occurred naturally (n = 862), group 2 – women whose pregnancy occurred as a result of in vitro fertilization (IVF) (n = 138). Miscarriage was confirmed by ultrasound performed at 6-10 weeks of pregnancy. A genetic study of POCs was carried out using chromosomal microarray analysis (CMA). In total, CA was detected in 580 samples (58%), and a normal molecular karyotype was determined in 420 (42%). CAs in abortive material during pregnancy loss are detected with a frequency of 59.05% in cases of natural conception and with a frequency of 51.05% in pregnancies resulting from IVF (p = 0.093). There were no statistically significant differences in the frequency and structure of CA in the study groups. Autosomal trisomies were most often detected. In our study, among all autosomal trisomies, the most common were trisomy 16, trisomy 22 and trisomy 15. Among the sex chromosome abnormalities, monosomy X was most often detected - in total, it was determined in 66 (6.6%) samples, which significantly exceeds the frequency of monosomy X among live births. Only in 0.2-0.3% of cases, when the embryo has monosomy X, pregnancy progresses and ends in a live birth. Copy number variations (CNVs) were often detected - a total of 52 (5.2%) samples with different CNVs, respectively 46 (5.3%) and 6 (4.3%) in groups 1 and 2. Detection of such abnormality is critically important, as it can be the result of carriage of a balanced CAs in one of the parents, which significantly increases the risk of miscarriage in the future. In pregnancies resulting from IVF, mosaicism in abortive material was more common, but the differences were not statistically significant. In group 1, mosaicism was detected in 66 (7.6%) cases and in group 2 - 13 (9.4%) cases. The IVF procedure does not increase the risk of CA in the embryo but also does not significantly reduce it. Considering the high frequency of CA in miscarriage, persons referred for IVF and with a history of idiopathic recurrent pregnancy loss should be informed about the possibility of PGT.

12 July 2021 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
EKE. V. Kudryavceva
E. V. Kudryavceva
VKV. V. Kovalev
V. V. Kovalev
NBN. N. Bayazitova
N. N. Bayazitova
NMN. M. Milyaeva
N. M. Milyaeva
AKA. V. Kaumova
A. V. Kaumova
Introduction. Preeclampsia is a hypertensive disorder of pregnancy that remains one of e leading causes of maternal and perinatal morbidity and mortality. The preventive strategy of prophylaxis with acetylsalicylic acid gives only a relative reduction in risk, and in a significant part of cases is ineffective. At the same time, the issue of preeclampsia prophylaxis is extremely relevant, since there are no effective methods for treating this condition, with the exception of the completion of gestation.Purpose of the study. Based on the scientific literature, to evaluate the effectiveness of aspirin in the prevention of preeclampsia and to determine the possible reasons for the lack of effectiveness of such prevention.Materials and methods. We conducted a search for scientific literature, as a result of which 39 sources were selected for the final scientific review (2010-2020). The PubMed, ResearchGate and Elibrary databases were used to search for scientific literature.Results and discussion. The article presents a literature review of the analysis of the effectiveness of aspirin for the prevention of preeclampsia over the past 5 years, describes the mechanism of action of aspirin, presents studies that confirm or refute the effectiveness of aspirin depending on the dosage and gestational age. Potential alternative agents for the prevention of preeclampsia in cases of aspirin ineffectiveness have been reviewed.Conclusion. Literature review data show that the effectiveness of aspirin for the prevention of preeclampsia depends on the chronobiological effect, compliance, gestational duration and dosage. It is necessary to continue research on the effectiveness of aspirin, and studies carried out on the Russian population will be of particular value for the Russian Federation.

30 January 2024 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
EKE.V. Kudryavtseva
E.V. Kudryavtseva
SDSvetlana Deryabina
Svetlana Deryabina
VKV.V. Kovalev
V.V. Kovalev
ENE.B. Nikolaeva
E.B. Nikolaeva
UVU.A. Vagushchenko
U.A. Vagushchenko
Screening for carriage of hereditary diseases in most cases is the only way to establish the degree of risk of genetic pathology. Currently, neither in Russia nor in any other country in the world there is a definite list of genes and diseases associated with them, for which carriers should be tested, as well as normative documents for its implementation. The purpose of this literature review was to identify the factors influencing the attitude of both representatives of the medical community and the general population to the idea of mass introduction of genetic testing for carriage of hereditary diseases in persons of active reproductive age. Mainly publications for the last decade are analyzed, as well as international testing and tactics in detecting carriage of hereditary disease. Ethical and legal aspects of obtaining and using genetic information are highlighted. Further study and improvement of the regulatory and legal framework of genetic testing, taking into account the achievements of modern genetics, the emergence of new diagnostic technologies, moral, ethical and religious aspects of this problem are required.

31 July 2025 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
KKKudryavtseva E.V. Kudryavtseva
Kudryavtseva E.V. Kudryavtseva
MMMangileva Ya.A. Mangileva
Mangileva Ya.A. Mangileva
PPPolushina L.G. Polushina
Polushina L.G. Polushina
MAMaksimova A.YU. Maksimova A
Maksimova A.YU. Maksimova A
KKKopenkin M.A. Kopenkin
Kopenkin M.A. Kopenkin
KVKovalev V.V. Kovalev V
Kovalev V.V. Kovalev V